Michael R. Edwards
Department of Respiratory Medicine
St Mary's Hospital
National Heart Lung Institute
Imperial College London
UK
Name/email consistency: high
- Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Edwards, M.R., Bartlett, N.W., Clarke, D., Birrell, M., Belvisi, M., Johnston, S.L. Pharmacol. Ther. (2009)
- Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct Cis-acting elements. Edwards, M.R., Haas, J., Panettieri, R.A., Johnson, M., Johnston, S.L. J. Biol. Chem. (2007)
- Protein kinase R, IkappaB kinase-beta and NF-kappaB are required for human rhinovirus induced pro-inflammatory cytokine production in bronchial epithelial cells. Edwards, M.R., Hewson, C.A., Laza-Stanca, V., Lau, H.T., Mukaida, N., Hershenson, M.B., Johnston, S.L. Mol. Immunol. (2007)
- New treatment regimes for virus-induced exacerbations of asthma. Edwards, M.R., Kebadze, T., Johnson, M.W., Johnston, S.L. Pulm. Pharmacol. Ther (2006)
- Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells. Edwards, M.R., Johnson, M.W., Johnston, S.L. Am. J. Respir. Cell Mol. Biol. (2006)
- IL-1beta induces IL-8 in bronchial cells via NF-kappaB and NF-IL6 transcription factors and can be suppressed by glucocorticoids. Edwards, M.R., Mukaida, N., Johnson, M., Johnston, S.L. Pulm. Pharmacol. Ther (2005)









